1. In this multi-database retrospective cohort study, rosuvastatin was found to be associated with slightly decreased risk of all-cause mortality ...
1. Major adverse cardiovascular events (MACE) were more likely to occur in patients with myocardial infarction (MI) with an optical ...
1. In this randomized controlled trial, bempedoic acid significantly reduced low-density lipoprotein (LDL) cholesterol levels in patients with increased cardiovascular ...
1. Risk of major adverse cardiac events increased amongst patients with a specific glomerular disease, including non-proliferative glomerulopathy, renal vascular ...
1. Patients with hypertension who received chlorthalidone did not have a lower occurrence of adverse cardiovascular outcomes compared to patients ...
1. In patients with stable chest pain and intermediate pretest probability of coronary artery disease (CAD), there was no difference ...
